A Top Selling Product and a CEO Buying Shares Sets This Cannabis Company Apart
Ash Stringer
June 19th, 2019
App, Exclusive, News, Top Story
Cannabis in Canada has a long and storied history, going back to 1923 when the plant was added to the Confidential Restricted List as a prohibited drug. Fast-forward to 2001 and regulators loosened laws to allow medical use to treat certain conditions under the MMPR (Marijuana for Medical Purposes Regulations). Then, in October 2017, history was made with Canada becoming the first G7 country to legalize recreational marijuana nationwide, creating a vibrant industry and multi-billion-dollar companies.
According to Statistics Canada, about 4.9 million Canadians aged 15 to 64 spent an estimated C$5.7 billion on cannabis for medical and non-medical purposes in 2017, spending that the government hopes to turn into revenue with the end of prohibition. Canadian bank CIBC estimates the legal Canadian market will grow to C$6.5 billion by 2020.
Long before recreational cannabis was legalized in the country, THC BioMed (CSE: THC) (OTCQX: THCBF) had planted its roots as a cultivator and researcher of medical marijuana in Kelowna, British Columbia. Through an Exemption 56, MMPR license, ACMPR (Access to Cannabis for Medical Purposes Regulations) license and now a Cannabis Act license, the company is an expert in the full gamut of production and regulations, offering its products and services throughout Canada and other parts of the world.
The company’s wholly-owned subsidiary, Clone Shipper Ltd., owns all rights to an eponymous product used to transport plants. Patent-pending technology of Clone Shipper covers an invention of an illuminated shipping container for live cannabis plants.
Click Here to Receive Additional Investor Updates
Strategic Motion
Making the moves to scale, THC has invested over $1.1 million in acquiring properties adjacent to its flagship facility. They needed it because in November THC earned a Cannabis Actand Cannabis Regulations license that allows it to produce and sell cannabis products on a large scale under the new Canadian laws.
To that end, THC now has 11 strata lots licensed for production, three more that are being submitted to Health Canada for review and another three under construction. All told, the company has 20 strata lots under its ownership, lease or contract to purchase in Kelowna.
The company, one of only 30 inaugural members of OTC Markets Group’s newly coined OTCQX Cannabis Index, recently entered into an agreement with the British Columbia Liquor Distribution Branch (BCLDB), the provincial wholesale distributor of non-medical cannabis, to supply several of its cannabis products exclusively throughout B.C.. Per the agreement, THC will be supplying 3.5-gram and 7-gram formats of select flower strains, including its THC Sativa Landrace, THC Indica Landrace, THC Hybrid Landrace, THC CBD Indica Landrace, Atomical Haze, West Coast Dream, Original Cheese and Jacky White.
West Coast Dream and Original Cheese are hybrid flowers containing an even mix of Indica and Sativa, differentiated by THC level. Jacky White is a Sativa-dominant hybrid.
The exclusive agreement strengthens the relationship between THC BioMed and BCLDB that kicked-off with the company delivering its first shipment of its Landrace line for the recreational market in October. Only weeks later, three of the strains and pre-rolls were listed on the BCLDB’s online store as best sellers, with the THC Hybrid flower and THC Hybrid pre-rolls taking the number one spots for their categories on launch day.
By the end of October, THC had made three shipments in order to restock sold-out products. Come the start of December, five shipments to BCLDB were sent, which now included THC CBD and Atomical Haze strains.
Also in December, the company expanded its sales channels into Saskatchewan, sending its first shipment of dried and pre-rolled cannabis to an undisclosed retailer in Saskatoon.
Click Here to Receive Additional Investor Updates
THC Makes Cannabis History
On the topic of pre-rolls, THC made history this month by becoming the first Canadian Licensed Producer to automate its pre-rolls containing 100% cannabis. With this accomplishment, the cannabis industry took another stride forward, as the word “joint” could one day be nearly obsolete in its traditional sense.
THC intends to soon begin shipment throughout its distribution network of its automated pre-rolls in four different strains of cannabis containing THC, and one strain of cannabis containing mostly CBD.
The momentum being gained translated to improving sales figures even ahead of the recent developments. During the quarter ended January 31, 2019, THC reported unaudited revenue of $474,041, up 55.2% from $305,448 in the year prior period. For the six months ended January 31, 2019, revenue totaled $753,181, a gain of 29.5% from $581,685 in the same period a year earlier.
THC Kiss Promise
As THC widens its flower and pre-roll distribution, the company is preparing to launch its first beverage, called THC Kiss. THC holds this developmental product in high regard, claiming the one-of-a-kind organic cannabis drink will deliver where all other similar products have failed. In part, its uniqueness comes from an extraction method that enhances cannabinoids that have never by utilized before.
Through its extensive research, THC believes it has the solution to overcome the obstacle of cannabis beverages causing fatigue and drowsiness. The company is confident that THC Kiss will be the first cannabis beverage to provide a mental and physical high for a short period of time following consumption. For now, though, the drink is under wraps while the Canadian government hammers out the details to legalize beverages and edibles containing cannabis.
Companies like Corona beer maker Constellation Brands (NYSE: STZ) have bet big on the future of cannabis drinks, investing $5 billion for a 38% stake in Canadian marijuana juggernaut Canopy Growth (NYSE: CGC) (TSX: CGC) to get into the space. Not to be left out, Molson Coors (NYSE: TAP) (TSX: TPX.B) teamed up with Quebec’s Hexo Corp. (NYSE American: HEXO) (TSX: HEXO) to launch a line of cannabis beverages called Truss, as the evolution of the green rush is aligning for cannabis beverages to become big business.
Ahead of any beverage legalization, THC CEO John Miller says he is satisfied with the progress his company is making. So pleased in fact that he recently bought another 500,000 shares of the company, boosting his position to about 23.3 million shares, or about 17.3% of THC’s outstanding shares.
Click Here to Receive Additional Investor Updates
To Learn more about THC BioMed (CSE: THC) (OTCQX: THCBF) visit the Company’s Website: https://thcbiomed.com
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ash Stringer
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
FSD Pharma is a publicly traded company on the Canadian Securities Exchange under the symbol HUGE. The Company, through its wholly-owned subsidiary FV Pharma Inc., holds an ACMPR license to cultivate cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). HUGE, made history on its first day of trading on the Canadian Securities […]
DNA Genetics has built and curated a seasoned genetic library and developed proven standard operating procedures for genetic selection, breeding, and cultivation.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
